Your institution may have access to this item. Find your institution then sign in to continue.
Title
Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States.
Authors
Kim, Jane J; Ortendahl, Jesse; Goldie, Sue J
Abstract
Women older than 30 years are the main beneficiaries of improved cervical cancer screening with human papillomavirus (HPV) DNA testing. The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent girls, is unclear in this age group.
Publication
Annals of internal medicine, 2009, Vol 151, Issue 8, p538